FDA's Process Validation Guidance Stresses Use of Statistical Controls
This article was originally published in The Gold Sheet
Executive Summary
FDA's process validation guidance puts a new emphasis on statistical controls. Like it or not, the guidance offers new flexibility. Also, it expands the focus of process validation from commercial scale-up to a lifecycle approach that includes process design studies as well as continuous verification during commercial manufacturing activities.